Zoetis

Acegon Injection for Cattle

£74.99

Indicated for the treatment of ovarian follicular cysts in cattle (cows and heifers) and in association with artificial insemination to optimise the time of ovulation.

Induction and synchronisation of oestrus and ovulation in combination with prostaglandin F2α (PGF2α) with or without progesterone as part of Fixed Time Artificial Insemination (FTAI) protocols:

In cycling cows. To be used in combination with PGF2α or analogue.
In cycling and non-cycling cows and heifers. To be used in combination with PGF2α or analogue and progesterone releasing device.

Legal Category : POM-V

This product requires a valid veterinary prescription for purchase

Prescriptions

I understand a valid veterinary prescription is required for this prescription-only medicine *
I will provide my prescription by: *
Email prescription *

Please e-mail your prescription to [email protected]
Post prescription *

Please send to: Dr Nicola Endersby MRCVS, Cura, 4 Saxon Court, Bishop Auckland DL14 7UA

Vet will send directly *

Please ask your vet to e-mail your prescription to [email protected] with your name and order number as a reference. (You will receive your order number once you have completed your purchase) Please confirm your Vet Practice name below

Your vet practice: *
Prescription *

Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe gif png pdf
Animal name(s) *

Product total

Options total

Grand total

View POM Delivery & Returns

Secure Checkout with

Accredited Retailer

Dosage & Administration

For intramuscular use.

Treatment of ovarian follicular cysts

100-150 micrograms of gonadorelin (as acetate) per animal (i.e. 2- 3 ml of the product per animal). If necessary, treatment can be repeated at intervals of 1-2 weeks.

In association with artificial insemination to optimise the time of ovulation, improving the chances that the treated cow will become fertile

100 micrograms of gonadorelin (as acetate) per animal (i.e. 2 ml of the product per animal). It must be administered at the same time as artificial insemination and/or 12 days after this.

The following timing of injection and insemination should be followed:

Injection should be performed between 4 and 10 hours after oestrus detection.

An interval of at least 2 hours between the injection of GnRH and artificial insemination is recommended.

Artificial insemination should be carried out in accordance with the usual field recommendations, i.e., 12 to 24 hours after oestrus detection.

Induction and synchronisation of oestrus and ovulation in combination with prostaglandin F2α (PGF2α) with or without progesterone as part of Fixed Time Artificial Insemination (FTAI) protocols

The following FTAI protocols have been commonly reported in the literature:

In cycling cows:

Day 0: Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product)

Day 7: Inject PGF2α or analogue (luteolytic dose)

Day 9: Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product)

Artificial insemination 16–20 hours later, or at observed oestrus if sooner.

Alternatively:

Day 0: Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product)

Day 7: Inject PGF2α or analogue (luteolytic dose)

Artificial insemination and injection of 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product) 60–72 hours later, or at observed oestrus if sooner.

In cycling and non-cycling cows and heifers:

Insert intravaginal progesterone releasing device for 7-8 days.

Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product) at progesterone device insertion.

Inject a luteolytic dose of PGF2α or analogue 24 hours prior to device removal.

FTAI 56 hours after removal of the device, or

Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product) 36 hours after progesterone releasing device removal and FTAI 16 to 20 hours later.

Product Description

Dosage & Administration

For intramuscular use.

Treatment of ovarian follicular cysts

100-150 micrograms of gonadorelin (as acetate) per animal (i.e. 2- 3 ml of the product per animal). If necessary, treatment can be repeated at intervals of 1-2 weeks.

In association with artificial insemination to optimise the time of ovulation, improving the chances that the treated cow will become fertile

100 micrograms of gonadorelin (as acetate) per animal (i.e. 2 ml of the product per animal). It must be administered at the same time as artificial insemination and/or 12 days after this.

The following timing of injection and insemination should be followed:

Injection should be performed between 4 and 10 hours after oestrus detection.
An interval of at least 2 hours between the injection of GnRH and artificial insemination is recommended.
Artificial insemination should be carried out in accordance with the usual field recommendations, i.e., 12 to 24 hours after oestrus detection.

Induction and synchronisation of oestrus and ovulation in combination with prostaglandin F2α (PGF2α) with or without progesterone as part of Fixed Time Artificial Insemination (FTAI) protocols

The following FTAI protocols have been commonly reported in the literature:

In cycling cows:

Day 0: Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product)
Day 7: Inject PGF2α or analogue (luteolytic dose)
Day 9: Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product)
Artificial insemination 16–20 hours later, or at observed oestrus if sooner.

Alternatively:

Day 0: Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product)
Day 7: Inject PGF2α or analogue (luteolytic dose)
Artificial insemination and injection of 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product) 60–72 hours later, or at observed oestrus if sooner.

In cycling and non-cycling cows and heifers:

Insert intravaginal progesterone releasing device for 7-8 days.
Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product) at progesterone device insertion.
Inject a luteolytic dose of PGF2α or analogue 24 hours prior to device removal.
FTAI 56 hours after removal of the device, or
Inject 100 micrograms of gonadorelin (as acetate) per animal (2 ml of the product) 36 hours after progesterone releasing device removal and FTAI 16 to 20 hours later.